Skip to content
Saturday, November 14, 2026
Discover the best online bingo games and challenges at Mode…

Individuals Stopping Slimming Injections Gain Back Weight Far More Rapidly Than Dieters

Image of pharmaceutical injection and weighing machine
Weight management involves long-term strategies.

A recent study indicates that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Research printed in a prominent medical journal points out that while overweight individuals often shed substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month after stopping.

"Users using these drugs must be aware of the risk of rapid rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting mass within about 18 months.

Weighing Approaches

The research, which looked at 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.

Scientists point out that individuals who shed pounds through dieting generally experience a less rapid weight regain—around 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Nutrition scientists believe the mechanism of the jabs explains the amplified regain.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing the hormone levels several times higher than normal might result in the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating far more likely."

A Chronic Issue?

Medical guidelines recommend the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the high risk of weight regain, the treatment is often long-term.

This view is echoed by pharmaceutical companies, who note that the results "emphasize the persistent nature of excess weight," similar to managing conditions like diabetes.

User Accounts

People who have come off the medication report a intense resurgence of cravings.

"It felt as if a switch activating and you become ravenous," recalled an individual.

This challenge is exacerbated if patients have not established sustainable lifestyle or habit changes during therapy.

Growing Use

Figures suggest that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.

  • Use is more common among females compared to men.
  • The 40s and 50s demographic shows the highest level of interest.
  • Many access the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while the jabs are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on integrated behavioural support.

About the author

Amanda Burch

Elena Cartwright is a passionate bingo blogger and game strategist with over a decade of experience in the online gaming industry.

Modern Bingo Studio

Type to search articles.